Deep brain stimulation induces rapidly reversible transcript changes in Parkinson's leucocytes

Journal of Cellular and Molecular Medicine

Volumn 16, Issue 7, 2012, Pages 1496-1507

  Soreq, Lilach ^a   Bergman, Hagai ^a,b,c   Goll, Yael ^c   Greenberg, David S ^c   Israel, Zvi ^b   Soreq, Hermona ^c  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^c HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Blood leucocytes; Deep brain stimulation; Exon microarrays; Parkinson's disease; Subthalamic nucleus

Indexed keywords

TRANSCRIPTOME;

ARTICLE; BLOOD; BLOOD CELL; BRAIN DEPTH STIMULATION; CASE CONTROL STUDY; GENE EXPRESSION PROFILING; HUMAN; LEUKOCYTE; MALE; METABOLISM; MIDDLE AGED; PARKINSON DISEASE; TREATMENT OUTCOME;

BLOOD CELLS; CASE-CONTROL STUDIES; DEEP BRAIN STIMULATION; GENE EXPRESSION PROFILING; HUMANS; LEUKOCYTES; MALE; MIDDLE AGED; PARKINSON DISEASE; TRANSCRIPTOME; TREATMENT OUTCOME;

EID: 84863108574     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2011.01444.x     Document Type: Article

References (64)

1. Fahn S. Description of Parkinson's disease as a clinical syndrome. Ann N Y Acad Sci. 2003; 991: 1-14.
2. Benabid AL, Pollak P, Seigneuret E, et al. Chronic VIM thalamic stimulation in Parkinson's disease, essential tremor and extra-pyramidal dyskinesias. Acta Neurochir Suppl (Wien). 1993; 58: 39-44.
3. Bergman H, Wichmann T, DeLong MR. Reversal of experimental parkinsonism by lesions of the subthalamic nucleus. Science. 1990; 249: 1436-8.
4. Benabid AL, Chabardes S, Mitrofanis J, et al. Deep brain stimulation of the subthalamic nucleus for the treatment of Parkinson's disease. Lancet Neurol. 2009; 8: 67-81.
5. Deuschl G, Schade-Brittinger C, Krack P, et al. A randomized trial of deep-brain stimulation for Parkinson's disease. N Engl J Med. 2006; 355: 896-908.
6. Weaver FM, Follett K, Stern M, et al. Bilateral deep brain stimulation versus best medical therapy for patients with advanced Parkinson disease: a randomized controlled trial. JAMA. 2009; 301: 63-73.
7. Scherzer CR, Eklund AC, Morse LJ, et al. Molecular markers of early Parkinson's disease based on gene expression in blood. Proc Natl Acad Sci USA. 2007; 104: 955-60.
8. Soreq L, Israel Z, Bergman H, et al. Advanced microarray analysis highlights modified neuro-immune signaling in nucleated blood cells from Parkinson's disease patients. J Neuroimmunol. 2008; 201-202: 227-36.
9. Segman RH, Goltser-Dubner T, Weiner I, et al. Blood mononuclear cell gene expression signature of postpartum depression. Mol Psychiatry. 2010; 15: 93-100, 2.
10. Segman RH, Shefi N, Goltser-Dubner T, et al. Peripheral blood mononuclear cell gene expression profiles identify emergent post-traumatic stress disorder among trauma survivors. Mol Psychiatry. 2005; 10: 500-13, 425.
11. Temperli P, Ghika J, Villemure JG, et al. How do parkinsonian signs return after discontinuation of subthalamic DBS?Neurology. 2003; 60: 78-81.
12. Henchcliffe C, Beal MF. Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis. Nat Clin Pract Neurol. 2008; 4: 600-9.
13. Kumaran R, Kingsbury A, Coulter I, et al. DJ-1 (PARK7) is associated with 3R and 4R tau neuronal and glial inclusions in neurodegenerative disorders. Neurobiol Dis. 2007; 28: 122-32.
14. Soreq L, Gilboa-Geffen A, Berrih-Aknin S, et al. Identifying alternative hyper-splicing signatures in MG-thymoma by exon arrays. PLoS ONE. 2008; 3: e2392.
15. Gardina PJ, Clark TA, Shimada B, et al. Alternative splicing and differential gene expression in colon cancer detected by a whole genome exon array. BMC Genomics. 2006; 7: 325.
16. Johnson JM, Castle J, Garrett-Engele P, et al. Genome-wide survey of human alternative pre-mRNA splicing with exon junction microarrays. Science. 2003; 302: 2141-4.
17. Dudoit S, Gentleman RC, Quackenbush J. Open source software for the analysis of microarray data. Biotechniques. 2003; Suppl: 45-51.
18. Spillantini MG, Schmidt ML, Lee VM, et al. Alpha-synuclein in Lewy bodies. Nature. 1997; 388: 839-40.
19. Scherzer CR, Grass JA, Liao Z, et al. GATA transcription factors directly regulate the Parkinson's disease-linked gene alpha-synuclein. Proc Natl Acad Sci USA. 2008; 105: 10907-12.
20. van Duijn CM, Dekker MC, Bonifati V, et al. Park7, a novel locus for autosomal recessive early-onset parkinsonism, on chromosome 1p36. Am J Hum Genet. 2001; 69: 629-34.
21. Partek®. Genomics Suite Software. 6.5 Beta, 6.09.1110 ed. St. Louis, MO, USA: Partek Incorporated, 1993-2009.
22. Hosack DA, Dennis G, Jr, Sherman BT, et al. Identifying biological themes within lists of genes with EASE. Genome Biol. 2003; 4: R70.
23. Dennis G, Jr, Sherman BT, Hosack DA, et al. DAVID: database for annotation, visualization, and integrated discovery. Genome Biol. 2003; 4: P3.
24. Zaidel A, Bergman H, Ritov Y, et al. Levodopa and subthalamic deep brain stimulation responses are not congruent. Mov Disord. 2010; 25: 2379-86.
25. Fuchs J, Tichopad A, Golub Y, et al. Genetic variability in the SNCA gene influences alpha-synuclein levels in the blood and brain. Faseb J. 2008; 22: 1327-34.
26. Zhong N, Kim CY, Rizzu P, et al. DJ-1 transcriptionally up-regulates the human tyrosine hydroxylase by inhibiting the sumoylation of pyrimidine tract-binding protein-associated splicing factor. J Biol Chem. 2006; 281: 20940-8.
27. Bonifati V, Rizzu P, van Baren MJ, et al. Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science. 2003; 299: 256-9.
28. Keyser RJ, van der Merwe L, Venter M, et al. Identification of a novel functional deletion variant in the 5'-UTR of the DJ-1 gene. BMC Med Genet. 2009; 10: 105.
29. Sun S, Zhang Z, Sinha R, et al. SF2/ASF autoregulation involves multiple layers of post-transcriptional and translational control. Nat Struct Mol Biol. 2010; Online.
30. Ben-Shaul Y, Bergman H, Soreq H. Identifying subtle interrelated changes in functional gene categories using continuous measures of gene expression. Bioinformatics. 2005; 21: 1129-37.
31. Alexa A, Rahnenfuhrer J, Lengauer T. Improved scoring of functional groups from gene expression data by decorrelating GO graph structure. Bioinformatics. 2006; 22: 1600-7.
32. Zuo F, Mertz JE. Simian virus 40 late gene expression is regulated by members of the steroid/thyroid hormone receptor superfamily. Proc Natl Acad Sci USA. 1995; 92: 8586-90.
33. Fujimura K, Katahira J, Kano F, et al. Selective localization of PCBP2 to cytoplasmic processing bodies. Biochim Biophys Acta. 2009; 1793: 878-87.
34. Pankratz N, Wilk JB, Latourelle JC, et al. Genomewide association study for susceptibility genes contributing to familial Parkinson disease. Hum Genet. 2009; 124: 593-605.
35. Kawamura H, Tomozoe Y, Akagi T, et al. Identification of the nucleocytoplasmic shuttling sequence of heterogeneous nuclear ribonucleoprotein D-like protein JKTBP and its interaction with mRNA. J Biol Chem. 2002; 277: 2732-9.
36. Yu P, Chen Y, Tagle DA, et al. PJA1, encoding a RING-H2 finger ubiquitin ligase, is a novel human X chromosome gene abundantly expressed in brain. Genomics. 2002; 79: 869-74.
37. Gorlich D, Hartmann E, Prehn S, et al. A protein of the endoplasmic reticulum involved early in polypeptide translocation. Nature. 1992; 357: 47-52.
38. Kagan JC, Su T, Horng T, et al. TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-beta. Nat Immunol. 2008; 9: 361-8.
39. Shaked I, Meerson A, Wolf Y, et al. MicroRNA-132 potentiates cholinergic anti-inflammatory signaling by targeting acetylcholinesterase. Immunity. 2009; 31: 965-73.
40. Ben-Shaul Y, Benmoyal-Segal L, Ben-Ari S, et al. Adaptive acetylcholinesterase splicing patterns attenuate 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-induced Parkinsonism in mice. Eur J Neurosci. 2006; 23: 2915-22.
41. Tracey KJ. The inflammatory reflex. Nature. 2002; 420: 853-9.
42. Gurevich M, Tuller T, Rubinstein U, et al. Prediction of acute multiple sclerosis relapses by transcription levels of peripheral blood cells. BMC Med Genomics. 2009; 2: 46.
43. Grisaru D, Pick M, Perry C, et al. Hydrolytic and nonenzymatic functions of acetylcholinesterase comodulate hemopoietic stress responses. J Immunol. 2006; 176: 27-35.
44. Reizenstein P. The haematological stress syndrome. Br J Haematol. 1979; 43: 329-34.
45. Toft P, Tonnesen E, Helbo-Hansen HS, et al. Redistribution of granulocytes in patients after major surgical stress. APMIS. 1994; 102: 43-8.
46. Olanow CW, Rascol O, Hauser R, et al. A double-blind, delayed-start trial of rasagiline in Parkinson's disease. N Engl J Med. 2009; 361: 1268-78.
47. Riley D, Lozano A. The fourth dimension of stereotaxis: timing of neurosurgery for Parkinson disease. Neurology. 2007; 68: 252-3.
48. Savica R, Rocca WA, Ahlskog JE. When does Parkinson disease start?Arch Neurol. 2010; 67: 798-801.
49. Kapranov P, Willingham AT, Gingeras TR. Genome-wide transcription and the implications for genomic organization. Nat Rev Genet. 2007; 8: 413-23.
50. Miller G. Neuropsychiatry. Rewiring faulty circuits in the brain. Science. 2009; 323: 1554-6.
51. Shah DB, Pesiridou A, Baltuch GH, et al. Functional neurosurgery in the treatment of severe obsessive compulsive disorder and major depression: overview of disease circuits and therapeutic targeting for the clinician. Psychiatry (Edgmont). 2008; 5: 24-33.
52. Kahane P, Depaulis A. Deep brain stimulation in epilepsy: what is next?Curr Opin Neurol. 2010; 23: 177-82.
53. Graff-Radford J, Foote KD, Mikos AE, et al. Mood and motor effects of thalamic deep brain stimulation surgery for essential tremor. Eur J Neurol. 2010; 17: 1040-6.
54. Kurian SM, Le-Niculescu H, Patel SD, et al. Identification of blood biomarkers for psychosis using convergent functional genomics. Mol Psychiatry. 2011; 16: 37-58.
55. Goshen I, Kreisel T, Ben-Menachem-Zidon O, et al. Brain interleukin-1 mediates chronic stress-induced depression in mice via adrenocortical activation and hippocampal neurogenesis suppression. Mol Psychiatry. 2008; 13: 717-28.
56. Gershon ES, Hamovit J, Guroff JJ, et al. A family study of schizoaffective, bipolar I, bipolar II, unipolar, and normal control probands. Arch Gen Psychiatry. 1982; 39: 1157-67.
57. Fahn S ER, Members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale; 1987.
58. http://www.affymetrix.com/support/technical/technotes/blood_technote.pdf.
59. Ashburner M, Ball CA, Blake JA, et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet. 2000; 25: 25-9.
60. Kanehisa M, Goto S, Furumichi M, et al. KEGG for representation and analysis of molecular networks involving diseases and drugs. Nucleic Acids Res. 2010; 38: D355-60.
61. Tatusov RL, Koonin EV, Lipman DJ. A genomic perspective on protein families. Science. 1997; 278: 631-7.
62. Bairoch A, Apweiler R, Wu CH, et al. The Universal Protein Resource (UniProt). Nucleic Acids Res. 2005; 33: D154-9.
63. Edgar R, Domrachev M, Lash AE. Gene expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res. 2002; 30: 207-10.
64. http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc.